MedPath

Acute Eosinophilic Myocarditis International Registry

Completed
Conditions
Myocarditis
Interventions
Other: No intervention
Registration Number
NCT06447935
Lead Sponsor
Niguarda Hospital
Brief Summary

Retrospective collection of clinical, histological, imaging data regarding patients with acute histologically-proven eosinophilic myocarditis.

Detailed Description

Eosinophilic myocarditis (EM) is an acute life-threatening inflammatory disease of the heart. We collect clinical, histologic, laboratory, diagnostic and imaging data regarding acute EM with a histological diagnosis and symptoms onset within 30 days from first medical contact from hospitals around the world. The main objective is to investigate and describe clinical presentation, main systemic conditions associated and outcomes of the first series of patients with acute myocarditis and histological evidence of eosinophilic infiltration within myocardium.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Acute Eosinophilic MyocarditisNo interventionPatients affected by Acute Eosinophilic Myocarditis with the following inclusion criteria: 1. histologically EM proven "borderline" (presence of inflammatory infiltrate) or "active" (presence of inflammatory infiltrate plus myocardial necrosis) myocarditis, according to the Dallas criteria; 2. acute presentation defined by the onset of cardiac symptoms within 30 days before admission.
Primary Outcome Measures
NameTimeMethod
Natural History of Eosinophilic Myocarditis3 year

Proportion of patients who die or need a heart transplantation from index admission.

Secondary Outcome Measures
NameTimeMethod
Natural History of Eosinophilic Myocarditis subgroups based on etiology3 years

Proportion of patients who die or need a heart transplantation from index admission dividing patients based on the underlying condition (for instance idiopathic, hypersensitivity, eosinophilic granulomatosis with polyangiitis,...)

Trial Locations

Locations (1)

ASST GOM Niguarda

🇮🇹

Milano, Italy

© Copyright 2025. All Rights Reserved by MedPath